Alicia Gil

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Venues

Orphanet journal of rare diseases

Global & regional health technology assessment

Applied health economics and health policy

Omakase Consulting

Universidad del País Vasco (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Omakase Consulting May 01 2014

Spain

CEO

Education History

Universidad del País Vasco

Spain

BSC :: Microbiology

Publications

Belén Sagastizabal, Inmaculada Calvo, Àngels Martínez-Ferrer, James Clancy, Álvaro Pérez, Alicia Gil, Rosa Bou
Current situation of osteogenesis imperfecta in Spain: results from a Delphi study. Orphanet journal of rare diseases 19 (1) (2024)
Belén Sagastizabal, Inmaculada Calvo, Àngels Martínez-Ferrer, James Clancy, Álvaro Pérez, Alicia Gil, Rosa Bou
Current situation of osteogenesis imperfecta in Spain: results from a Delphi study. Orphanet journal of rare diseases 19 (1) (2024)
Maria R Abad Sazatornil, Carmen Alerany, Laia Alsina, Eduardo López Granados, Olaf Neth, Jose Luis Poveda, Jacques G Rivière, Carlos Rodríguez-Gallego, Joanne B Tutein Nolthenius, Raquel Figueiredo, Silvia Subías Labazuy, Alicia Gil
Determining value in the treatment of activated PI3Kδ syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders. Global & regional health technology assessment 11 (2024)
Maria R Abad Sazatornil, Carmen Alerany, Laia Alsina, Eduardo López Granados, Olaf Neth, Jose Luis Poveda, Jacques G Rivière, Carlos Rodríguez-Gallego, Joanne B Tutein Nolthenius, Raquel Figueiredo, Silvia Subías Labazuy, Alicia Gil
Determining value in the treatment of activated PI3Kδ syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders. Global & regional health technology assessment 11 (2024)
Belén Sagastizabal, Inmaculada Calvo, Àngels Martínez-Ferrer, James Clancy, Álvaro Pérez, Alicia Gil, Rosa Bou
Current situation of osteogenesis imperfecta in Spain: results from a Delphi study. Orphanet journal of rare diseases 19 (1) (2024)
Christian Domingo, Mario Fernandez, Noe Garin, Javier Milara, Ignacio Moran, Irantzu Muerza, Adalberto Pacheco, Carlos Teruel, Roy Bentley, Rafael Subiran, Alicia Gil
Determining What Represents Value in the Treatment of Refractory or Unexplained Chronic Cough from the Perspective of Key Stakeholders in Spain Using Multi-Criteria Decision Analysis. Applied health economics and health policy (2022)
Alberto Jiménez, Arantza Ais, Amélie Beaudet, Alicia Gil
Determining the value contribution of selexipag for the treatment of pulmonary arterial hypertension (PAH) in Spain using reflective multi-criteria decision analysis (MCDA). Orphanet journal of rare diseases 13 (1) (2018)

Alicia Gil.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alicia Gil